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osting by EAbstract The goal of the treatment of patients with glaucoma is to prevent disability or, if disabil-
ity already exists, to repair the disability or at the least to prevent further disability from developing.
To achieve these goals requires knowing what will happen if there is no treatment and what will
happen if there is treatment. That is, one must know the possible beneﬁts from the therapy in com-
parison to the damage caused by the therapy. As we will demonstrate, the classic risk factors do not
provide accurate estimates of the development of disability and do not answer these two questions.
The most helpful clues are provided by what the patient says, by whether the disc is damaged and by
whether the disc is deteriorating.
The severity of disease is best estimated by the nature of the optic disc and how it changes. This
report is primarily focused on increasing the skill of the physician in being able to estimate the nat-
ure of the optic disc and how that changes. This does not, however, lessen the tremendous impor-
tance of careful history-taking and of gonioscopy. In this report, however, we focus on the
evaluation of the disc.
Currently disc evaluation is often not adequate because of poor examination techniques, reliance
on cup/disc ratios, and reliance on the results of image analyzers. We will present here the Disc
Damage Likelihood Scale, which is a user-friendly method which correlates accurately with visual
ﬁeld changes.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.928 3960.
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ﬁeld loss. CCT = Central corneal thickness; DDLS = Disc
Damage Likelihood Scale.1. Introduction
For many years physicians based the diagnosis and manage-
ment of glaucoma on the level of intraocular pressure. The ini-
tial belief was that pressure above 21 mm Hg was abnormal
and below 21 mm Hg was normal (Leydhecker et al., 1958).
Consequently, glaucoma diagnosis and treatment were simple:
people with pressures over 21 mm Hg had glaucoma and were
treated, and people with pressures below 21 mm Hg did not
have glaucoma and were not treated. We know now this was
simplistic, not simple. Ninety-three percent of people with
pressures over 21 mm Hg never develop glaucoma damage,
and around one third to one half of those with glaucoma have
pressures in the normal range (Sommer et al., 1991).
Unfortunately, there is presently a similarly simplistic way
of thinking simplistically about glaucoma, speciﬁcally to ‘‘just
lower the intraocular pressure to or below 12 mm Hg.’’ This
belief is based on an incorrect interpretation of the results of
the AGIS study (The Advanced Glaucoma Intervention Study
(AGIS), 2000). The AGIS study appeared to show that indi-
viduals whose pressures were 12 mm Hg or below for seven
years failed to have progressive glaucoma damage, whereasFigure 1 Glaucoma Color Graph. The stage of disease is graded
considering the amount of disc damage estimated by DDLS. The
optic discs may be graded in three zones: green, yellow or red. In
the green zone, which comprises DDLS of 1–4, the patients do not
have deﬁnite damage. When a patient is in the yellow zone (with a
DDLS of 5–7), the optic nerve is deﬁnitely damaged, but the
person may still be asymptomatic. It is certain that the optic disc is
not normal. Finally, when a person is already in the red zone (with
a DDLS of 8, 9 or 10), that is, the person already has a disability.
The patient may have decreased quality of life or impaired ability
to perform the daily activities.those with pressures around 20 developed three out of 20 units
of visual ﬁeld loss.
However, the study did not actually show that. Fourteen
percent of individuals in the study whose intraocular pressuresFigure 3 Statistical signiﬁcance of various characteristics of
patients with glaucoma, related to their likelihood of their
developing visual ﬁeld loss as observed in the Advanced Glaucoma
Intervention Study (AGIS). The slope of the visual ﬁeld (VF)
refers to the rapidity with which the visual ﬁeld is worsening in
units of visual ﬁeld loss/years. ‘‘AGIS VFS’’ indicates the amount
of visual ﬁeld loss according to the AGIS system of staging visual
ﬁelds. IOP mean indicates the mean intraocular pressure in
mmHg. IOP ﬂuctuation refers to the ﬂuctuation of intraocular
pressure. Eye (right) refers to comparison of the IOP in the right
eye versus the left eye. (Histogram created on the basis of data
from citation 8.)
The disc as the basis of treatment for glaucoma 383were 12 mm Hg or below got worse faster than the subjects
whose pressures were 20 mm Hg. This is an important point,
because the simplistic misinterpretation of the results of the
AGIS study has resulted in many ophthalmologists working
to get all patients with glaucoma to pressures of 12 mm Hg
or below. The consequence has been a massive overtreatment
of many patients with glaucoma. These overtreatments can
result in inconvenience, cost, embarrassment, damage to the
surfaces of the eye, loss of vision, infection, systemic abnor-
malities and even death. No treatment is justiﬁed unless it is
clear that without the treatment the patient will develop some
type of disability.
In the Olmsted County Study, around one-third of the pa-
tients went blind (Hattenhauer et al., 1998). In our practice at
Wills Eye Institute, less than one-tenth percent go blind (Eid
et al., 2003). These are, of course, different populations. How-
ever, there is a reasonable chance that at least part of the dif-
ference in outcome is related to the method in which care is
provided including minimizing overtreatment. By and large,
the patients in the Olmsted County Study were treated on
the basis of pressure. Our patients are treated on the basis of
the history and the evaluation of the disc.
At Wills, the essential aspects of the care of patients with
glaucoma, in addition to looking at pressure, include (1) a
careful history with sufﬁcient information on estimated life
expectancy; (2) assessing the anterior chamber angle accurately
enough to know its nature; (3) measuring the intraocular pres-
sure with an applanation tonometer; (4) evaluating the optic
disc with careful staging of the amount of damage; and (5)
considering psychophysical characteristics, such as visual acu-
ity, visual ﬁeld and contrast sensitivity.Figure 4 Individual data points from the analysis made by Caprioli i
those who did not get worse in four categories, speciﬁcally related to
amount of visual ﬁeld loss, and the mean intraocular pressure. The dar
those who did not. The ﬁgures at the top of each bar are the mean valu
have a similar denominator. Zero represents the lowest value and 100The goal of treatment at Wills is to prevent disability in pa-
tients or, if disability already exists, to repair the disability or
at the least to prevent further disability from developing. To
achieve these goals requires knowing what will happen if there
is no treatment and what will happen if there is treatment.
That is, one must know the possible beneﬁts from the therapy
in comparison to the damage caused by the therapy. The use of
the Glaucoma Graph (Fig. 1) is very helpful in this regard
(Spaeth and Paulus, 2010).
Two important questions are ‘‘Who is disabled by glau-
coma?’’ and ‘‘Who will become disabled by glaucoma?’’ As
we will demonstrate, the classic risk factors do not provide
accurate estimates of the development of disability and do
not answer these two questions. The most helpful clues are
provided by what the patient says, by whether the disc is dam-
aged, and by whether the disc is deteriorating.
Fig. 2 is a graphic representation of the likelihood that a
person will develop visual ﬁeld loss in association with various
risk factors. Note this is not disability but just ﬁeld loss. The
likelihood of developing disability is much lower. Note that
even when patients have central corneal thickness less than
550 micra and intraocular pressures above 27 mm Hg, two-
thirds of the patients will not develop any visual ﬁeld loss with-
in seven years (Gordon et al., 2002). On the other hand, if the
Disc Damage Likelihood Scale (DDLS) is 5 or greater, 95% of
the patients will have worsening of their visual ﬁeld.
Fig. 3 is an analysis of the AGIS data performed by Joseph
Caprioli, in which he found that the major risk factors for the
worsening of the visual ﬁeld were the rate of change of the vi-
sual ﬁeld and the age of the patient (Nouri-Mahdavi et al.,
2005). The level of intraocular pressure and the ﬂuctuationn Fig. 3, analyzing those patients whose visual ﬁelds got worse and
the rapidity of worsening visual ﬁeld, the age of the patient, the
k bars are those who developed visual ﬁeld loss, and the light bars
es. The units on the Y-axis represent the ranges, adjusted so as to
the highest.
Figure 5 The mean and standard deviations of the cup/disc ratio in normal subjects, glaucoma suspects and those with glaucoma (left).
Distribution of cup/disc ratios for the same groups (right). (Modiﬁed from citation 11.)
384 C. Zangalli et al.of intraocular pressure were not statistically signiﬁcant in this
regard. However, Fig. 4 shows something a little bit different.
Fig. 4 illustrates that patients with a rapid rate of ﬁeld deteri-
oration always have continuing visual ﬁeld progression. In
contrast, age by itself does not predict whether an individual
will have progressive glaucoma damage. The oldest patients
did not get worse. Even though intraocular pressure was not
statistically signiﬁcant, when the intraocular pressure was
markedly elevated, all the patients got worse.
Risk factors continue to be used in ways that do not make
sense. Wilensky, Podos and Becker pointed out in 1974 that
‘‘the individual parameters were not good predictive indicators
(including intraocular pressure)’’ (Wilensky et al., 1974). Quig-
ley et al. wrote in 1994, ‘‘The relationship of the development
of ﬁeld loss to race, myopia, family history of glaucoma and
medical history are more complex than has been presumed’’
(Quigley et al., 1994).
One of the great errors we make in deciding on treatment is
to base the care of individuals on population statistics. Fig. 5,
from Caprioli’s study, shows on the left that the cup/disc ratios
in patients with glaucoma are larger than cup/disc ratios in pa-
tients without glaucoma, on a population basis (Caprioli and
Miller, 1988). Yet, on the right looking at the individual pa-
tients, one can see that it is not until the cup/disc ratio getsFigure 6 Discs A, B and C are of average size and disc D is of
large size. The cup/disc ratios of the three smaller discs are about
the same, but disc B is probably healthy and discs A and C are
certainly abnormal. The c/d ratio does not tell the well from the
sick. Disc D has the biggest cup. It also has the greatest rim area
and is likely not to be glaucomatous.up to about .8 or more that it becomes even a fairly reliable
indicator that the patient has glaucoma. Furthermore, the
smallest cup/disc ratio occurred in a patient with glaucoma.
Visual ﬁelds are, of course, important in estimating the
well-being of patients with glaucoma. However, trying to de-
cide on whether visual ﬁelds are actually worsening or whether
they represent glaucoma is far more complex than is usually
admitted. In 2002, Weinreb wrote that the speciﬁc methods
to identify true glaucomatous progression have yet to be deter-
mined. This situation is still true (Lee et al., 2002).
In any individual, (1) the predictive value of intraocular
pressure in determining whether the optic disc and/or visual
ﬁeld will deteriorate is almost non-existent unless the intra-
ocular pressure is in a range which is always abnormal, that
is above 35 mm Hg (Foster et al., 2003); (2) there is virtually
no predictive value of an individual’s intraocular pressure in
determining who will become disabled; (3) we know that it is
possible to prevent visual ﬁeld loss in patients with glaucoma,
yet many patients with glaucoma still get progressive visual
ﬁeld loss; (4) visual ﬁeld changes are often misleading; (5)
the signiﬁcance of glaucoma is a function of the severity of
the disease and the duration of the disease; and (6) the likeli-
hood that a patient will become disabled due to glaucoma is
(i) a function of the severity and duration of the disease; (ii)
the self-care abilities of the patient; (iii) the skill of the physi-
cian; and (iv) the adaptability of the patient.2. Severity of disease
The severity of disease is best estimated by the nature of the
optic disc and how it changes. This report is primarily focused
on increasing the skill of the physician in being able to estimate
the nature of the optic disc and how that changes. This does
not, however, lessen the tremendous importance of careful his-
tory-taking and of gonioscopy. In this report, however, we fo-
cus on evaluation of the disc.
Currently disc evaluation is often poor because of poor
examination techniques, reliance on cup/disc ratios, and reli-
Figure 7 The Disc Damage Likelihood Scale (DDLS). This grading system is based on the radial width of the neuroretinal rim measured
at its thinnest point. The unit of measurement is the rim/disc ratio, that is, the radial width of the rim compared to the diameter of the disc
in the same axis. When there is no rim remaining, the rim/disc ratio is 0. The circumferential extent of rim absence (0 rim/disc ratio) is
measured in degrees. For small discs (diameter <1.50 mm) the DDLS stage should be increased by 1; for large discs (diameter >2.00 mm)
the DDLS stage should be decreased by 1.
Figure 8 Optic nerves. (A) This illustrates large healthy discs with large cup/disc ratios from patients who have been followed for more
than 30 years with no disc change or any other sign of glaucoma. (B) Shows a small glaucomatous optic disc without a large cup/disc ratio,
but with an eccentric cup exhibiting an inferior focal notch associated with marked visual ﬁeld loss. (C) Depicts a large disc with
glaucomatous cupping.
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Disc Damage Likelihood Scale, which is a user-friendly meth-
od which correlates accurately with visual ﬁeld changes.
Cup/disc ratios are not satisfactory ways of evaluating the
health of the optic nerve. They do not take into account the
position of the cup or the size of the disc. Fig. 6 illustrates four
discs. Disc A is certainly pathologic. Disc B, which has the
same cup/disc ratio as disc A, is probably normal. Disc D,
which has much the largest cup/disc ratio, is probably at least
as healthy as and perhaps even healthier than disc B.
The Disc Damage Likelihood Scale is a method of estimat-
ing the health of the disc, based on the width of the neuroreti-
nal rim adjusted for the disc size, or if rim is already absent, the
extent of circumferential loss of neuroretinal rim (Bayer et al.,
2002). The system is illustrated in Fig. 7.
To determine a score on the Disc Damage Likelihood Scale,
the ﬁrst step is to measure the disc with any of the standard
techniques, such as using a high-plus lens or direct ophthal-
moscopy. The second step is to identify the narrowest area
of the rim in terms of rim/disc ratio. The largest possible
rim/disc ratio is 0.5.
It is not true that large cups mean glaucoma. Fig. 8a shows
the discs of two different patients, where both discs are very
large. Neither patient has glaucoma. Neither patient has visual
ﬁeld loss. These are very large discs with narrow rims but with-
out ﬁeld loss. The patients have been followed for over ten
years each, and there has been no change.
In an average-sized disc where the rim is extremely narrow,
but present, the DDLS is a 5. However, in a small disc this
would be a DDLS of 6, and in a large disc it would be a DDLS
of 4. Fig. 8b illustrates such a disc, which is small, but in which
the rim is very narrow. In an average-sized disc, this would be
a 5, but because it is a small disc it is graded as a 6. Fig. 8c
illustrates a large disc which, were it an average disc, would
be graded as DDLS of 7. However, because it is a large disc,
it is a DDLS of 6. It is important to note, then, that the health
of the disc in Fig. 8c is no better than the health of the disc in
Fig. 8b.
The ﬁrst challenge, then, is to determine the amount of
damage that is present in the disc, that is, what is the stage
of the disease. This can be graphed by using the Glaucoma
Graph (Fig. 1). This is divided into three zones, the Green
Zone, the Yellow Zone and the Red Zone. The DDLS stages
1-4 constitute the Green Zone. When a disc is in this area it
is not possible on the basis of one examination to determine
whether the disc is abnormal or normal. If the disc is found
changed, that is, goes from a DDLS of 1 to a DDLS of 3, then
one can say with certainty that the DDLS of 3 is abnormal.
In the Green Zone, patients are asymptomatic and it is not
possible to determine whether glaucoma is actually present,
unless a change (as just mentioned) has been documented. In
the Yellow Zone, however, the patient deﬁnitely has some
abnormality such as an abnormal visual ﬁeld, or for purposes
of this discussion, a DDLS of 5, 6 or 7. The patient deﬁnitely
has glaucoma but is still asymptomatic, because the amount of
damage is not sufﬁcient to cause symptoms. The fact that a
person is in the Yellow Zone and has glaucoma, however, does
not necessarily mean that the process is active or that the per-
son needs treatment. At minimum, it does mean that at some
time glaucoma damage developed. In the Red Zone, the pa-
tient has symptoms and experiences disability such as difﬁcultyin the dark, trouble reading, or one of the many symptoms
caused by glaucomatous visual loss.
Thus, the stage of disease is estimated by considering the
amount of disc damage as measured by the Disc Damage Like-
lihood Scale.
Other units could be used for the Y-axis on the Glaucoma
Graph, such as the number of ganglion cells. However, at this
time it is not feasible to count ganglion cells. Visual ﬁelds are
also not satisfactory for the Y-axis because they show changes
only relatively late in the disease and show high variability. As
mentioned, cup/disc ratios or intraocular pressure are not sat-
isfactory for staging of glaucoma.3. Rate of change
It is not adequate merely to estimate the stage of the disease. It
is also necessary to determine the rate at which the disease is
changing. This requires establishing serial points, so that these
points can be recorded sequentially and compared. The slope
of the curve determines whether or not the condition is active
or quiescent (in a patient who is not treated).4. Estimated remaining years
The goal of treatment is to prevent individuals from getting
into the Red Zone, or, if in the Red Zone already, to prevent
them from developing further disability. When one is consider-
ing patients in the Green or the Yellow Zone, one has to know
how long the disease will continue to progress as well as the
rate of change. For many chronic conditions, including
chronic glaucoma, the disease will continue for as long as
the person lives. Thus, an estimate of the patient’s remaining
years is an essential aspect of proper therapy. Lee has demon-
strated that it is possible to predict quite accurately whether an
individual will live for four more years (Lee et al., 2006). This
can be done by taking into account factors, such as general
health, lifestyle and family history. Age is a poor indicator
of the remaining years. For example, a 92-year-old healthy wo-
man has only a three percent chance of dying within four
years, whereas a 50-year-old overweight male who smokes cig-
arettes, has a history of a myocardial infarction, and has high
blood pressure has only a 50% chance of dying in less than
four years. A healthy 96-year-old woman has a 97% chance
of living to be 100. A 50-year-old overweight male smoker
has no chance of living to be 100 years old.5. Putting it all together to help patients
Combining a careful history with an accurate evaluation of the
disc provides a useful way of directing treatment. Consider a
74-year-old banker in good health who has an estimated 20
remaining years. He has noted deteriorating vision, has a
DDLS of 9, and has intraocular pressure on therapy of 13.
He is already in the Red Zone. Thus, any further deterioration
will result in an increase in his disability. Therefore, the basic
approach to his treatment must be to prevent any further dam-
age to his optic nerve. Because he is getting worse with pres-
sures that are presumably somewhere around 13 mm Hg, it
is apparent his pressure must be lower than 13 mmHg. Assum-
The disc as the basis of treatment for glaucoma 387ing he is already on maximum medical therapy, he needs either
a laser or a ﬁltering procedure with the goal of further IOP
reduction.
Consider a 64-year-old beautician who is in fair health, with
an estimated 10 remaining years. She is quite unhappy with her
vision and states she is continually getting worse. However, the
history is not reliable; her intraocular pressures are 26 mm Hg
in the right eye and 22 mm Hg in the left eye, on no treatment;
and various medications have been tried, but each one has
caused intolerable symptoms. She has been seen by us because
she is referred for surgery. The disc in the left eye is slightly lar-
ger than that in the right eye, with a slightly larger cup; but
there is good rim tissue in all areas. Both of her discs are
DDLS’s of 4. She is in the green zone. It does not seem that
she is actually getting worse. There is probably no need for
any treatment at this time.
A 72-year-old engineer is referred because of optic nerves,
which are believed to be glaucomatous, and intraocular pres-
sures which are believed to be too high. The engineer is in
excellent health and has an estimated 20 remaining years. He
has no ocular symptoms other than discomfort from the med-
ications that have been tried, he is a reliable historian, and the
intraocular pressure on latanoprost and dorzolamide is 19 mm
Hg in the right eye and 18 mm Hg in the left eye. His optic
discs are extremely large, with very narrow rims which are in-
tact in all areas; it is not surprising he has no visual ﬁeld loss,
because they are DDLS’s of 4 in each eye. He is also in the
Green Zone on the Glaucoma Graph and no treatment is nec-
essary. When his topical treatment was stopped, his pressures
rose to 21 mm Hg in each eye. He was advised that probably
no medications are necessary, and he is now being followed
off medications.
A 56-year-old chemist is seen because his wife insisted that
he have a second opinion. The chemist works in a pharmaceu-
tical company as a research scientist. He has an estimated
remaining 30 years. He believes his vision is still ﬁne, although
his wife complains that is now a dangerous driver and that she
will no longer ride in the car with him at night. He denies this,
but it becomes clear that he probably is not an accurate obser-
ver. He was told, by another ophthalmologist whom he con-
sulted because he thought he needed a change in his glasses,
that he had glaucoma and was advised to start therapy. The
ophthalmologist told him his intraocular pressures were
15 mm Hg in the right eye and 16 mm Hg in the left eye,
and because the patient ‘‘knew’’ that those pressures were nor-
mal, he also ‘‘knew’’ that he did not have glaucoma. His optic
nerves are severely damaged, with a DDLS of 6 in the right eye
and 7 in the left. On the Glaucoma Graph, he is in the Yellow
Zone. When he was shown the Glaucoma Graph and it was ex-
plained to him that nobody starts in the Yellow Zone, and that
he had moved from the Green Zone down into the Yellow
Zone and would soon be in the Red Zone, he immediately
understood that something was seriously wrong and he recog-
nized that treatment was necessary.
In summary, the optic discs are vitally important in diag-
nosing and managing patients with glaucoma. Cup/disc ratios
are not of much help in this regard because they do not take
into account the size of the disc or the location of the cup.
Therefore, they are not accurate estimates of whether a disc
is damaged or not. Thus, cup/disc ratio should NOT be used
and is clearly outdated.There is a little amount of time to spend with each patient,
and so it is essential to concentrate on what really counts. The
things that really matter are (1) what the patient says; (2) the
nature of the anterior chamber angle; (3) intraocular pressures
above 35 mm Hg and asymmetry of more than 4 mmHg; (4)
the nature of the optic disc; (5) the rate of change of the disc;
(6) the estimated remaining years of life; and (7) pertinent
socioeconomic factors. In order to provide appropriate care,
it is necessary to concentrate on these things; almost every-
thing else is just for reﬁning the impression and the plan.References
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